In this white paper, learn how CFOs today are increasingly taking center stage in value creation. Also discover how CFOs are initiating and driving comprehensive Revenue Management projects to connect the disparate pieces of the revenue lifecycle in support of their new role as strategic business partners.
In an era where top-line growth is slowing due to shorter product lifecycles, growing buyer sophistication, and enhanced regulatory scrutiny, the need to reign in lost revenue and "get the numbers right" has never been greater for big and small pharmaceutical companies alike.
These pressures and market dynamics are driving pharmaceutical and biotechnology CFOs to initiate comprehensive programs to connect the disparate pieces of the revenue lifecycle. In the process, they are improving revenue and regulatory compliance through stronger pricing controls, enforcement, and enhanced revenue planning — and successfully turning a top-line problem into a bottom-line success story.
Offered Free by: Model N
See All Resources from: Model N
750 University Avenue | Suite 200 | Los Gatos, CA 95032
Resources: FAQ | Legal Notices